• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS PASCAL PRECISION; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS PASCAL PRECISION; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number 20000ISM
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Stroke/CVA (1770); Thrombosis/Thrombus (4440)
Event Date 01/19/2024
Event Type  Injury  
Manufacturer Narrative
The event is captured by edwards lifesciences under complaint #: (b)(4).The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
 
Event Description
Edwards received notification of a pascal precision ace procedure in mitral position.During procedure, a small thrombus was observed via trans-oesophageal echocardiogram (toe) attached to the tip of the implant when steering down to the valve.Before procedure, thrombus on the right access site for the central line was observed.Therefore, the decision was to change to left side to get successful access.However, sludge in the left atrial appendage was observed.During intervention, a p10 had to be retrieved as it was not possible to successfully grasp the posterior mitral leaflet (pml) due to dense chordae.As reported, the physician did not want to change the guide sheath (gs) to avoid the risk of disturbing the sludge in the appendage with a wire to secure the transseptal access.The p10 was bailed out successfully and the ace was prepared and introduced instead.When steering down to the valve, a small thrombus like structure was observed at the tip of the ace via toe.It was decided to proceed with the procedure under heavy heparinization of the patient (act 400).Act was controlled every 15 minutes during the entire procedure and was never under 250.As reported, there was no different treatment than heparinization during the procedure.Procedure went successfully and without further incidents.Thrombus was not observable anymore after implantation.Two hours after the procedure, patient was reported to have stroke symptoms and was under treatment by the neurologic department.Thrombus was successfully removed by the treatment.Planned treatment for the stroke was thrombectomy, however it is not confirmed if it was needed in the end.Patient was reported to be stable, was brought back to cardiologic station and planned to be extubated the same day.
 
Manufacturer Narrative
The following sections were updated/corrected/added: b4, b5, g3, g6, h2 and h10.
 
Event Description
Additional information received as per internal imaging evaluation review, starting mitral regurgitation (mr) grade was 4 and final mr grade was 1.
 
Manufacturer Narrative
The complaint for thrombus formation was confirmed- other empirical evidence based on the accounts of the edwards clinical specialist present during the procedure.Available information suggests the procedural complications likely contributed to the event due to challenges encountered during implant delivery such as the described sludge and dense chords.Based on extensive complaint investigations and reviews, it has been identified that events are not associated with device malfunctions or manufacturing nonconformances.Per the instructions for use (ifu), intracardiac thrombus formation and device thrombosis are known potential adverse events which have been identified as possible complications associated with standard cardiac catheterization procedures.Potential patient risk factors such as atrial fibrillation, systemic disease (e.G., systemic lupus erythematosus, inflammation, and damage to various body tissues, including joints, skin, kidneys, heart, lungs, blood vessels, and brain), valvular disease itself and reduced cardiac ejection fraction can contribute to increased risk of thrombus/thrombosis.These events will continue to be monitored and complaints trending, and control limits are managed and assessed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS PASCAL PRECISION
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
cassandra cook
1 edwards way
irvine, CA 92614
5743778277
MDR Report Key18697023
MDR Text Key335297379
Report Number2015691-2024-00970
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P220003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Followup,Followup
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number20000ISM
Device Lot Number11459002
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/13/2024
Supplement Dates Manufacturer Received02/27/2024
02/27/2024
Supplement Dates FDA Received02/27/2024
02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexMale
-
-